ContextVision AB: Year-end report 2023 – Underlying growth and scaling up the business
Q4 Highlights · New advanced X-ray product Altumira™ Plus with scatter correction released · Participation in world’s largest medical imaging conference, Radiological Society of North America (RSNA) · Increasing interest from customers and OEMs in our products · Strategic investments in Point of Care Ultrasound (POCUS), R&D and Quality Management Q4 Financial Data · Record Q4 Net Sales of 33.2 MSEK (32.6) · Operating result of 3.2 MSEK (9.1) · EBITDA of 5.2 MSEK (11.0) · Dividend payout of 11.6 MSEK · Earnings per share of 0.04 SEK (0.10) Full Year